Dr. Gebhard Neyer is currently the acting site head of the Ferring Research Institute and brings with him 25 years of experience in biopharma R&D, project/portfolio management, team leadership, and R&D management.
During his decade at Ferring Research, moving from project leader to head of project & portfolio management, he has been involved in the successful delivery of over half a dozen clinical candidates across all therapeutic areas of interest to Ferring and is currently the chairman of the Portfolio Committee as well as the FRI representative on the global Early R&D Committee.
Prior to Ferring he managed various projects in neurology, oncology and ophthalmology – from IND-enabling studies up to ph. 2b – as a project leader at Neurocrine Biosciences and team leader at Pfizer, Inc.
He launched his industry career at a start-up in the diabetes space – ultimately acquired by Johnson & Johnson – after completion of his post-doc with George Olah at the University of Southern California.
Gebhard is a native of Austria with a Ph.D. in chemistry from the Technische Universität München, Germany, and an MBA from California State University, Long Beach.
Dr. Adrienne Day is the Senior Director of Business Development for Ferring Research Institute, Inc. She has more than 20 years of experience in the biotechnology and biopharmaceutical industries, and has worked in the non-profit, for-profit and startup environments.
Prior to joining Ferring Dr. Day ran a successful consulting practice. She has previously served as Vice President of Business Development at what is now the Sanford Burnham Prebys Medical Discovery Institute, Vice President of Business Development Conforma Therapeutics, Senior Director of Business Development at Molecumetics Ltd., Associate Director of Corporate Development at Ligand Pharmaceuticals. She was Ligand Pharmaceuticals’ first Project Manager, and began her biotechnology career at Invitrogen Corporation where she held various positions.
Dr. Day received her B.Sc., B.Sc. Honors, and Ph.D. degrees in Biochemistry from the University of Adelaide, Australia. She completed her postdoctoral training at the University of Southern California with Dr. Amy Lee and at the La Jolla Cancer Research Center in the laboratory of Dr. Eva Engvall.
Paul Acosta joined Ferring in May 2012 and is dedicated to upholding The Ferring Philosophy – People Come First.
Prior to joining Ferring, Mr. Acosta held several progressively more senior Human Resources leadership positions at Genoptix, a Novartis Company, Avanir Pharmaceuticals and Chugai Pharma USA, a member of the Roche Group. He has more than 25 years of experience in all facets of Human Resources including: recruitment, performance management, compensation, employee relations, training and development, succession planning and organization design. Paul holds a Bachelor’s degree in Business Administration from National University, San Diego, California.